Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of molecular biology of differentiated thyroid cancer for clinical prognostication.

Endocrine-related cancer - 1 Nov 2016

Marotta Vincenzo, Sciammarella Concetta, Colao Annamaria, Faggiano Antongiulio

Abstract excerpt

Although cancer outcome results from the interplay between genetics and environment, researchers are making a great effort for applying molecular biology in the prognostication of differentiated thyroid cancer (DTC). Nevertheless, role of molecular characterisation in the prognostic setting of DTC is still nebulous. Among the most common and well-characterised genetic alterations related to DTC, including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary, Follicular
Share to Genes, p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to Prognosis

Share to Promoter Regions, Genetic

Share to Proto-Oncogene Proteins B-raf

Share to Telomerase

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 27578827
DOI: 10.1530/ERC-16-0372

Genes

TERT
BRAF
RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Application of molecular biology of differentiated thyroid cancer for clinical prognostication.PMID 27578827Read ↗

BRAF and TERT promoter mutations: clinical application in thyroid cancer.Semantic proximity Read ↗

The prognostic power of gene mutations in thyroid cancerSemantic proximity Read ↗

How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?Semantic proximity Read ↗

Prognostic Stratification of Highly Differentiated Thyroid Cancer Based on Molecular Genetic Studies.Semantic proximity Read ↗

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.Semantic proximity Read ↗

TERT promoter mutations and long-term survival in patients with thyroid cancer.Semantic proximity Read ↗

TERT promoter-mutated thyroid carcinomas: prognostic and histologic insights according to the WHO 2022 classification.Semantic proximity Read ↗

High prevalence of potential molecular therapeutic targets in poorly differentiated thyroid carcinomaSemantic proximity Read ↗

Molecular Markers Guiding Thyroid Cancer ManagementSemantic proximity Read ↗

Molecular Alterations in Thyroid Carcinoma.Semantic proximity Read ↗

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.Semantic proximity Read ↗

Clinical use of Molecular Data in Thyroid Nodules and CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.